About
OptimOva is a patented blood test method developed at Oslo University Hospital. The test personalises hormone dosing by fine-tuning the routine dosing standard and adjusting the prescribed dose to the patient's needs. The objective of this novel test is to optimise egg production, thus increasing the chances for having enough good quality embryos and ultimately improving chances for pregnancy and live birth delivery. In addition, excess good quality embryos are cryopreserved for future cycles, eliminating the need for further hormonal treatment.
Technologies
Wordpress.com
Gmail
Google Apps
Nginx
WordPress.org
Mobile Friendly
Quantcast
Keywords
personalize medicine
infertility
in vitro fertilisation
medical diagnostics
heathcare
startup
medical science
medical equipment manufacturing
biotechnology
clinical trial development
ivf biomarker assay development
egg cell number optimization
ivf treatment optimization
healthcare technology
fertility biomarker
fertility biomarker blood test
clinical trial coordination
patient-specific hormone management
treatment safety
clinical decision support
biomarker analysis
personalized medicine
ivf hormone fine-tuning
blood biomarker
ivf hormone management
hormone dosage
biomarker-based hormone adjustment
patient-specific fertility treatment
healthcare
fertility biomarker assay
Company Information
-
Employees 3
-
Founded 2018
Location
Oslo, Oslo, Norway
